PetIQ, Inc. Class A Stock News

EAGLE, Idaho and NEW YORK, Oct. 25, 2024 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication, health and wellness company, today announced the successful completion of its acquisition by Bansk Group (“Bansk”), a consumer-focused private investment firm dedicated to building distinctive consumer brands, in an all-cash transaction valued at approxim...

Reports Merger Agreement with Bansk Group Approved by Stockholders and Anticipates a Closing Date of October 25, 2024 Reports Merger Agreement with Bansk Group Approved by Stockholders and Anticipates a Closing Date of October 25, 2024

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of PetIQ, Inc. (NASDAQ: PETQ) to Bansk Group for $31.00 per share in cash is fair to PetIQ shareholders. Halper Sadeh encourages PetIQ shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpers...

NEW YORK, Aug. 09, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

NEW YORK, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

MILWAUKEE, Aug. 7, 2024 /PRNewswire/ -- Ademi LLP is investigating PetIQ (Nasdaq: PETQ) for possible breaches of fiduciary duty and other violations of law in its transaction with Bansk. Click here to learn how to join our investigation https://www.ademilaw.com/case/petiq-inc or call Guri Ademi toll-free at 866-264-3995.

Pet medications wholesaler PetIQ agreed to a $1.5 billion buyout Wednesday, sending shares into the stratosphere.

PetIQ Inc. PETQ, -0.63%, an Idaho-based pet wellness company, said Wednesday it's agreed to be acquired by investment firm Bansk Group for $31 a share in cash, or about $1.5 billion. The price is equal to a premium of about 41% over the 30-day volume-weighted average stock price as of Tuesday, and a premium of about 51% to the closing stock price on that day.